Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan

NCT06717191 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

296

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: biosimilar insulin glargine

Sponsor

Life for a Child Program, Diabetes Australia

Collaborators

[object Object]